Overview Financials News + Filings Key Docs Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
|
|
Humacyte, Inc.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/14/2023 |
8-K
| Quarterly results |
| 07/26/2023 |
8-K
| Quarterly results |
| 06/08/2023 |
8-K
| Submission of Matters to a Vote of Security Holders Interactive Data |
| 05/12/2023 |
8-K
| Quarterly results |
| 03/24/2023 |
8-K
| Quarterly results |
| 03/13/2023 |
8-K
| Regulation FD Disclosure Interactive Data |
| 12/12/2022 |
8-K
| Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year, Financial Statements and Exhibits ... |
| 09/20/2022 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 08/12/2022 |
8-K
| Quarterly results |
| 06/13/2022 |
8-K
| Quarterly results |
| 05/13/2022 |
8-K
| Quarterly results |
| 03/29/2022 |
8-K
| Quarterly results |
| 01/10/2022 |
8-K
| Regulation FD Disclosure, Financial Statements and Exhibits Interactive Data |
| 12/28/2021 |
8-K/A
| Quarterly results |
| 12/27/2021 |
8-K
| Quarterly results |
| 11/15/2021 |
8-K
| Other Events, Financial Statements and Exhibits Interactive Data |
| 11/12/2021 |
8-K
| Quarterly results |
| 09/02/2021 |
8-K
| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements... |
| 08/27/2021 |
8-K
| Entry into a Material Definitive Agreement, Completion of Acquisition or Disposition of Assets, Unregistered Sales of Equity ...|
Docs:
|
"Second Amended and Restated Certificate of Incorporation of Humacyte, Inc",
"By Laws of Humacyte, Inc",
"Cover Page Interactive Data File (embedded within the Inline XBRL document)",
"(1)",
"HUMACYTE, INC. 2021 EMPLOYEE STOCK PURCHASE PLAN The purpose of the Plan is to provide eligible employees of the Company and each Designated Company with opportunities to purchase shares of the Company’ s Common Stock. 1,030,033 shares of Common Stock have been approved and reserved for this purpose. Commencing on January 1, 2022 and on each subsequent anniversary thereof , the number of shares of Common Stock reserved and available for issuance under the Plan will automatically increase in an amount equal to 1% of the total number of shares of the Company’ s capital stock outstanding on December 31 of the preceding year; provided, however that the Board may act prior to January 1st of a given year to provide that the increase for such year will be a lesser number of shares of Common Stock...",
"HUMACYTE, INC.",
"Letter from Marcum LLP to the SEC",
"Subsidiaries of Humacyte, Inc",
"Audited financial statements of Legacy Humacyte as of and for the years ended December 31, 2020 and 2019 and the unaudited financial statements of Legacy Humacyte as of and for the six months ended June 30, 2021 and 2020",
"Unaudited pro forma condensed combined financial information of Humacyte, Inc. for the year ended December 31, 2020 and as of and for the six months ended June 30, 2021" |
|
| 08/25/2021 |
8-K
| Submission of Matters to a Vote of Security Holders, Other Events, Financial Statements and Exhibits Interac... |
| 08/04/2021 |
8-K
| Other Events, Financial Statements and Exhibits Interactive Data |
| 06/07/2021 |
8-K
| Investor presentation |
| 05/26/2021 |
8-K
| Regulation FD Disclosure, Other Events, Financial Statements and Exhibits |
| 05/21/2021 |
8-K
| Regulation FD Disclosure, Other Events, Financial Statements and Exhibits |
| 05/20/2021 |
8-K
| Regulation FD Disclosure, Other Events, Financial Statements and Exhibits |
| 05/13/2021 |
8-K
| Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review, Other Events |
| 04/21/2021 |
8-K
| Regulation FD Disclosure, Other Events, Financial Statements and Exhibits |
| 04/14/2021 |
8-K
| Regulation FD Disclosure, Other Events, Financial Statements and Exhibits |
| 03/05/2021 |
8-K
| Quarterly results |
| 02/17/2021 |
8-K
| Quarterly results |
| 02/17/2021 |
8-K
| Quarterly results |
| 11/06/2020 |
8-K
| Other Events, Financial Statements and Exhibits |
| 09/28/2020 |
8-K
| Other Events, Financial Statements and Exhibits |
| 09/22/2020 |
8-K
| Entry into a Material Definitive Agreement, Unregistered Sales of Equity Securities, Amendments to Articles of Incorporation ...|
Docs:
|
"Underwriting Agreement, by and between the Company and Oppenheimer & Co. Inc., as representative of the several underwriters",
"Amended and Restated Certificate of Incorporation",
"Warrant Agreement, by and between the Company and Continental Stock Transfer & Trust Company, as warrant agent",
"Letter Agreement, by and among the Company, its officers, its directors and the Sponsor",
"Investment Management Trust Agreement, by and between the Company and Continental Stock Transfer & Trust Company, as trustee",
"Registration Rights Agreement, by and among the Company and certain security holders",
"Administrative Support Agreement, by and between the Company and Constellation Alpha Holdings LLC",
"Unit Subscription Agreement, by and between the Company and the Sponsor",
"Unit Subscription Agreement, by and between the Company and Oppenheimer & Co. Inc",
"Unit Subscription Agreement, by and between the Company and Northland Securities, Inc" |
|
|
|